Descripción
ENVIAR EMAIL
With the rate of new drug approvals on the rise, clients have made major strides in increasing productivity while also responding to revised regulations to better protect manufacturers. Pharmaceutical companies continue to invest in both new and existing facilities and have identified biotechnology as a targeted, emerging industry.
“I want to recognize the outstanding performance by Jacobs in the delivery of this critical project, which will manufacture Lucentis and other drugs for treating unmet medical needs. On behalf of Genentech, I am pleased to note the success of the ECP-1 Project and to point to the leadership of Jacobs as the key contributor to the project’s execution on time, under budget, and safe.” — Ramesh Kamath, Genentech Senior Director Corporate Engineering
Project types:
- Process-intensive development facilities
- Laboratories
- Pilot plants
- Large-scale manufacturing
Project types:
- Facility of the Future
- Retrofits
- Greenfield manufacturing
- Modular facilities
- Master planning projects
Más información sobre este producto consulte en: http://www.globalskm.com/workwithus/ourindustries/pharma.aspx#Overview
